NASDAQ:BTX

Eterna Therapeutics Inc.

Stock

USD

Last Close

0.20

17/10 04:00

Market Cap

1.05M

Beta: 0.79

Volume Today

2.56M

Avg: 85.42K

PE Ratio

−0.42

PFCF: −0.39

Overview Financials Filings people Ownership API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-2.05M -	-7.29M 256.18%	-122.31M 1,577.49%	-24.58M 79.90%	-21.67M 11.84%
depreciation and amortization	3.17M -	98K 96.91%	459K 368.37%	497K 8.28%	1.12M 125.96%
deferred income tax		-19.24M -	9.35M 148.60%		2.90M -
stock based compensation		91K -	5.24M 5,652.75%	2.94M 43.94%	1.24M 57.68%
change in working capital	-37K -	-999K 2,600%	-2.35M 135.24%	3.71M 257.87%	-2.12M 157.06%
accounts receivables	-248K -	1.67M 774.60%	-659K 139.39%	-262K 60.24%	527K 301.15%
inventory	337K -	52K 84.57%	485K 832.69%	262K 45.98%
accounts payables	669K -	-1.73M 358.59%	-485K 71.97%	2.03M 519.38%	-2.90M 242.48%
other working capital	-795K -	-994K 25.03%	-1.69M 70.12%	1.68M 199.11%	254K 84.84%
other non cash items	1.66M -	19.24M 1,059.04%	86.12M 347.62%	-3.54M 104.11%	-1.89M 46.71%
net cash provided by operating activities	2.74M -	-8.10M 395.23%	-23.49M 189.94%	-20.98M 10.69%	-20.41M 2.71%
investments in property plant and equipment	-1.09M -	-39K 96.44%	-154K 294.87%	-297K 92.86%	-19K 93.60%
acquisitions net	29K -		-22.71M -	250K 101.10%
purchases of investments
sales maturities of investments
other investing activites			119K -
net cash used for investing activites	-1.06M -	-39K 96.34%	-22.74M 58,212.82%	-47K 99.79%	-19K 59.57%
debt repayment	-1.04M -	-310K 70.33%	-942K 203.87%	-2K 99.79%	-16.25M 812,499.95%
common stock issued		4.36M -	62.52M 1,334.39%	19.71M 68.48%	320K 98.38%
common stock repurchased					-16.25M -
dividends paid	-16K -		-8K -	-16K 100%	-16K 0%
other financing activites	-37K -	620K 1,775.68%	10K 98.39%	-109K 1,190%	48.76M 44,830.27%
net cash used provided by financing activities	-1.10M -	4.67M 525.23%	61.59M 1,219.02%	19.58M 68.21%	16.56M 15.44%
effect of forex changes on cash	92K -
net change in cash	673K -	-3.47M 615.75%	15.36M 542.38%	-1.44M 109.40%	-3.87M 168.07%
cash at beginning of period	2.59M -	5.10M 97.25%	1.63M 68.05%	16.98M 942.02%	11.45M 32.61%
cash at end of period	3.26M -	1.63M 49.98%	16.98M 942.02%	15.54M 8.50%	7.58M 51.26%
operating cash flow	2.74M -	-8.10M 395.23%	-23.49M 189.94%	-20.98M 10.69%	-20.41M 2.71%
capital expenditure	-1.09M -	-39K 96.44%	-154K 294.87%	-297K 92.86%	-19K 93.60%
free cash flow	1.65M -	-8.14M 593.33%	-23.64M 190.44%	-21.27M 10.02%	-20.43M 3.98%

All numbers in USD (except ratios and percentages)